The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTDE.L Regulatory News (TDE)

  • There is currently no data for TDE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PIP _ Cycle II (2015-2018)

28 Oct 2015 16:49

RNS Number : 7739D
Telefonica SA
28 October 2015
 

In accordance with Article 47 of Royal Decree 1362/2007 of October 19, and Article 82 of the Spanish Stock Market Act, (Ley del Mercado de Valores), TELEFÓNICA, S.A. hereby discloses the following

 

 

RELEVANT INFORMATION

 

 

In connection with the long-term incentive plan consisting in the granting of shares of Telefónica, S.A. - called Performance & Investment Plan ("PIP")- aimed at Telefonica Group Executives including Executive Directors of Telefónica, S.A., and approved by the Annual General Shareholders Meeting held on May 30, 2014, it is informed that the Board of Directors of Telefónica, S.A., following a relevant favorable report of the Nominating, Compensation and Corporate Governance Committee, has approved, with regard to the second cycle (2015-2018) of the aforementioned Plan, the amount of theoretical shares to be assigned to the Executive Board Members and Directors of the Company that are detailed in the Schedule attached, and the maximum possible number of shares to be received by them, in the event of fulfillment of the Co-investment requirement and of maximum achievement of the Total Shareholder Return (TSR) established on the aforementioned Plan.

 

The number of theoretical shares assigned to this second cycle (2015-2018) is the same as the one assigned in the first cycle (2014-2017) at this time last year.

 

Madrid, October 28, 2015.

 

SCHEDULE I

 

List of Directors and Executives who are Beneficiaries of the

Performance & Investment Plan

 (Second cycle / 2015-2018)

 

 

 

First name and surname

Theoretical

shares assigned

(without co-investment)

%

Share Capital

Maximum

Number

of Shares *

%

Share Capital

Mr. César Alierta Izuel

324,000

0.006

506,250

0.010

Mr. José María Álvarez-Pallete López

192,000

0.003

300,000

0.006

Mr. Ángel Vilá Boix

120,000

0.002

187,500

0.003

Mr. Guillermo Ansaldo Lutz

104,000

0.002

162,500

0.003

Mr. Ramiro Sánchez de Lerín García-Ovies

60,000

0.001

93,750

0.001

Mr. Eduardo Navarro de Carvalho

60,000

0.001

93,750

0.001

 

 

* Maximum number of shares to receive in case of fulfillment of the co-investment requirement and of maximum achievement of the TSR objective.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKEPALLSFFF
Date   Source Headline
26th Apr 20188:55 amRNSFinancial Highlights January-March 2018
25th Apr 20185:50 pmRNSAGM Official Calling and Proposals
25th Apr 20185:17 pmRNSTEF-Composition of the Board of Directors
25th Apr 20187:52 amRNSTEF-Composition of the Board of Directors
5th Apr 20187:37 amRNSTEF - UK Spectrum
26th Mar 20185:15 pmRNSDate of Publication Jan-March18 Results
23rd Mar 201810:35 amRNSTEF - Capital Structure and IFRS
22nd Mar 20185:09 pmRNSTEF - Settlement of the Issuance
21st Mar 20183:28 pmRNSResult of Tender Offer of Bonds
16th Mar 20187:00 amRNSTEF - Facility Agreement
14th Mar 20187:00 amRNSTEF - Issuance of Securities
13th Mar 20188:46 amRNSTender Offer for Notes
28th Feb 20187:05 amRNSIssue of Notes
23rd Feb 20187:00 amRNSFiling of Form 20F 2017
22nd Feb 20181:35 pmRNSAnnual Report Remuneration Directors 2017
22nd Feb 20189:14 amRNSDoc re. 2017 Annnual Financial Report
22nd Feb 20189:04 amRNSPresentation on Quarterly Results
22nd Feb 20188:59 amRNSAnnual Financial Report 2017
22nd Feb 20188:40 amRNSQuartely results January-December 2017
1st Feb 20187:55 amRNSNew organizational structure
1st Feb 20187:53 amRNSAppointment of a member of the Board of Directors
22nd Jan 20184:49 pmRNSTEF- Date of publication of 2017 Jan-Dec results
15th Jan 20186:22 pmRNSTEF - Issue of EMTN Notes
22nd Dec 20177:39 amRNSTEF-Voluntary resignation Massanell
7th Dec 20174:53 pmRNSTEF - Settlement of the Issuance
29th Nov 20176:24 pmRNSTEF - Issuance of Securities
14th Nov 20177:00 amRNSTEF - Telxius exercise option
26th Oct 20177:55 amRNSDoc re. Presentation on quarterly results JanSep17
26th Oct 20177:35 amRNS2017 Third Quarter Financial Results
26th Oct 20177:33 amRNSFinancial Highlights Jan-Sep 2017
24th Oct 20175:23 pmRNSTEF- Closing of the sale of stake of Telxius
26th Sep 20174:47 pmRNSTEF- Date of publication of 2017 Jan- Sept results
22nd Sep 20172:02 pmRNSAdmission of new shares
21st Sep 20177:00 amRNSTEF-Maturity of convertible bonds
5th Sep 20176:19 pmRNSTEF-Issue of Notes
30th Aug 20177:25 amRNSColtel capital increase
27th Jul 201712:17 pmRNSTEF- Arbitration award Coltel
27th Jul 20178:12 amRNSTEF- Arbitration award Coltel
27th Jul 20178:01 amRNSDoc re. Presentation Quarterly results Jan-June17
27th Jul 20177:40 amRNSTEF - Quarterly resuls January-June 2017
27th Jul 20177:23 amRNSTEF - First Half-Yearly Financial Report
26th Jul 20175:14 pmRNSTEF - Composition of the Board of Directors
25th Jul 20172:30 pmRNSAppointment of Chief Operating Officer
27th Jun 20174:47 pmRNSTEF- Date of publication of 2017 Jan-June results
9th Jun 20173:56 pmRNSDividend Declaration
9th Jun 20173:47 pmRNSResult of AGM 2017
11th May 20179:40 amRNSDoc re.Presentation quarterly results Jan-March17
11th May 20179:29 amRNSTEF - 2017 First quarter financial results
11th May 20179:22 amRNSTEF - Financial Highlights January-March2017
4th May 20175:32 pmRNSAGM Official Calling and Proposals

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.